Global Radiation Oncology Market to Witness Accelerating Growth by 2027, due to Rapid Development in Technology and Treatment Techniques by Leading Market Players – Exclusive Report [248 Pages] by Research Dive
March 23, 2021 09:00 ET
|
Research Dive
New York, USA, March 23, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global radiation oncology market is forecasted to garner a revenue of $10,679.7 million by...
Cancer Immunotherapy Market To Reach USD 242.86 Billion By 2026 | Reports And Data
July 17, 2019 11:02 ET
|
Reports and Data
New York, July 17, 2019 (GLOBE NEWSWIRE) -- Increasing demand for cancer immunotherapy in hospitals, cancer research centers, and clinics coupled with high investment in R&D of cancer...
Combination Immunotherapy of Pembrolizumab with the Galectin-3 Inhibitor GR-MD-02 Shows Promising Early Results in Treatment of Advanced Melanoma from a Phase 1b Clinical Trial
November 13, 2017 08:30 ET
|
Galectin Therapeutics Inc.; Providence Cancer Institute
NORCROSS, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, and Providence Cancer Institute today...